Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL344707 | 0.78 | ALDH1A1 (0.38) | GAA | |
| SCHEMBL3804683 | 0.78 | GAA (0.31) | GAA | |
| SCHEMBL4642553 | 0.75 | — | — | |
| SCHEMBL3680404 | 0.72 | DGAT1 (0.36) | GAA | |
| SCHEMBL7692060 | 0.72 | DGAT1 (0.36) | GAA | |
| SCHEMBL28557899 | 0.72 | DGAT1 (0.36) | GAA | |
| SCHEMBL7077697 | 0.71 | — | — | |
| SCHEMBL1960824 | 0.71 | GAA (0.33) | GAA | |
| SCHEMBL27900649 | 0.70 | KDM4E (0.33) | GAA | |
| SCHEMBL20560564 | 0.69 | ALDH1A1 (0.33) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2268782-A2 | MULTILAYER FRAGRANCE ENCAPSULATION | AMCOL INTERNATIONAL CORPORATION (US) | 2011-01-05 | — | — | EP | claimed |
| US-20090258812-A1 | MULTILAYER FRAGRANCE ENCAPSULATION | AMCOL INTERNATIONAL CORPORATION (US) | 2009-10-15 | — | — | US | claimed |
| WO-2009126960-A2 | MULTILAYER FRAGRANCE ENCAPSULATION | AMCOL INTERNATIONAL CORPORATION (US) | 2009-10-15 | — | — | WO | claimed |
| US-8188022-B2 | Multilayer fragrance encapsulation comprising kappa carrageenan | AMCOL INTERNATIONAL CORPORATION (US) | 2012-05-29 | — | — | US | disclosed |
| US-7977288-B2 | Microparticle coated with two types of cationic polymers, the first having a lower molecular weight than the second; e.g. polydiallyldimethylammonium chloride and a cationic cellulose; increased deposition of benefit agent; shampoos, cleansers | AMCOL INTERNATIONAL CORPORATION (US) | 2011-07-12 | — | — | US | disclosed |
| US-7871972-B2 | Compositions containing benefit agents pre-emulsified using colloidal cationic particles | AMCOL INTERNATIONAL CORPORATION (US) | 2011-01-18 | — | — | US | disclosed |
| EP-2268782-A2 | MULTILAYER FRAGRANCE ENCAPSULATION | AMCOL INTERNATIONAL CORPORATION (US) | 2011-01-05 | — | — | EP | disclosed |
| US-20100119561-A1 | Compositions Having a Performance Indicator | AMCOL INTERNATIONAL CORPORATION (US) | 2010-05-13 | — | — | US | disclosed |
| EP-2155156-A2 | COMPOSITIONS HAVING A PERFORMANCE INDICATOR | Amcol International Corporation (US) | 2010-02-24 | — | — | EP | disclosed |
| US-20090258812-A1 | MULTILAYER FRAGRANCE ENCAPSULATION | AMCOL INTERNATIONAL CORPORATION (US) | 2009-10-15 | — | — | US | disclosed |
| WO-2009126960-A2 | MULTILAYER FRAGRANCE ENCAPSULATION | AMCOL INTERNATIONAL CORPORATION (US) | 2009-10-15 | — | — | WO | disclosed |
| US-20090162408-A1 | COMPOSITIONS CONTAINING CATIONICALLY SURFACE-MODIFIED MICROPARTICULATE CARRIER FOR BENEFIT AGENTS | AMCOL INTERNATIONAL CORPORATION (US) | 2009-06-25 | — | — | US | disclosed |
| US-20090148392-A1 | COMPOSITIONS CONTAINING BENEFIT AGENTS PRE-EMULSIFIED USING COLLOIDAL CATIONIC PARTICLES | AMCOL INTERNATIONAL CORPORATION (US) | 2009-06-11 | — | — | US | disclosed |
| US-20090022818-A1 | HIGH-FOAMING, VISCOUS CLEANSER COMPOSITION WITH A SKIN CARE AGENT | AMCOL INTERNATIONAL CORPORATION (US) | 2009-01-22 | — | — | US | disclosed |
| WO-2008060778-A2 | COMPOSITIONS HAVING A PERFORMANCE INDICATOR | AMCOL INTERNATIONAL CORPORATION (US) | 2008-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100119561-A1 | Compositions Having a Performance Indicator | STRA6, EXOSC5, CD63 | GAA 205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.